December 20 | 2022
2cureX reaches 2022 geographic rollout goal of 20 countries
Read more
November 24 | 2022
2cureX publishes interim report for the third quarter and first nine months of 2022
Read more
November 22 | 2022
Invitation to 2cureX webcast and conference call on November 24, 2022
Read more
November 14 | 2022
2cureX discloses status of 2022 plans, goals for 2023 and its estimates of potential market development in the coming years
Read more
November 1 | 2022
Invitation to 2cureX Strategy Deep-Dive
Read more
October 11 | 2022
Independent market survey shows great demand for 2cureX product portfolio
Read more
October 6 | 2022
Co-inventor of 2cureX patents awarded Nobel Prize in Chemistry
Read more
September 29 | 2022
2cureX terminates liquidity provision service
Read more
September 19 | 2022
Change of distribution partner in Portugal
Read more
September 1 | 2022
2cureX expands distribution of IndiTreat® to Romania
Read more
August 25 | 2022
2cureX publishes interim report for the second quarter and first half of 2022
Read more
August 22 | 2022
Invitation to 2cureX Webcast on August 25, 2022.
Read more
August 8 | 2022
Announcement from 2cureX extra general meeting
Read more
July 20 | 2022
Notice of extra general meeting in 2cureX AB
Read more
July 1 | 2022
Dr. Raphael Gruber joins 2cureX as new Medical Director
Read more
June 28 | 2022
2cureX expands distribution of IndiTreat® to Israel
Read more
June 7 | 2022
2cureX AB announces share purchase by the company’s Chairman of the Board of Directors and Executive Management
Read more
May 31 | 2022
Strengthening the IndiTreat® distribution in North Europe
Read more